Deseret Mutual Benefit Administrators decreased its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 4.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,686 shares of the company’s stock after selling 211 shares during the quarter. Deseret Mutual Benefit Administrators’ holdings in Colgate-Palmolive were worth $426,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of CL. Matauro LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth about $828,000. AR Asset Management Inc. acquired a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $1,636,000. Drum Hill Capital LLC bought a new stake in Colgate-Palmolive during the 4th quarter worth approximately $302,000. Capital Advisory Group Advisory Services LLC increased its holdings in Colgate-Palmolive by 3.6% during the 4th quarter. Capital Advisory Group Advisory Services LLC now owns 3,830 shares of the company’s stock valued at $348,000 after purchasing an additional 132 shares in the last quarter. Finally, Cordatus Wealth Management LLC raised its position in Colgate-Palmolive by 1.1% in the 4th quarter. Cordatus Wealth Management LLC now owns 22,915 shares of the company’s stock valued at $2,083,000 after purchasing an additional 251 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently commented on CL. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. UBS Group lowered their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, Raymond James reissued an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $101.16.
Colgate-Palmolive Price Performance
Shares of CL opened at $89.56 on Friday. The stock has a market cap of $72.68 billion, a P/E ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $84.45 and a 1 year high of $109.30. The stock’s 50-day moving average price is $88.94 and its two-hundred day moving average price is $95.91. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business posted $0.87 EPS. On average, equities analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Breakout Stocks: What They Are and How to Identify Them
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Options Trading – Understanding Strike Price
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.